Groundbreaking HIV vaccine design strategy shows promise in proof-of-principle tests

The new vaccine strategy centers on stimulating the immune system to produce broadly neutralizing antibodies (bnAbs) against HIV. These special antibodies are capable of neutralizing many different strains of the fast-mutating virus by binding to important yet difficult-to-access regions of the virus surface that don’t vary much from strain to strain.

Leave a Reply

Your email address will not be published. Required fields are marked *